T2 Biosystems (NASDAQ:TTOO – Get Free Report) will be announcing its earnings results after the market closes on Monday, May 6th. Individual interested in listening to the company’s earnings conference call can do so using this link.
T2 Biosystems Trading Up 1.9 %
TTOO stock opened at $3.72 on Friday. T2 Biosystems has a 52 week low of $2.60 and a 52 week high of $70.00. The company has a fifty day simple moving average of $3.63 and a two-hundred day simple moving average of $4.46.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group cut their target price on T2 Biosystems from $12.00 to $3.00 and set a “hold” rating on the stock in a research report on Monday, April 29th.
T2 Biosystems Company Profile
T2 Biosystems, Inc, an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
See Also
- Five stocks we like better than T2 Biosystems
- How to Choose Top Rated Stocks
- Appleās Earnings Show Investors Its Strength and Its Weakness
- How to Calculate Return on Investment (ROI)
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Business Services Stocks Investing
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.